Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Malcolm

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Virus Research|September 9, 2005
Trans-complementation of HCV replication by non-structural protein 5AXiao Tong, Bruce A Malcolm
Analytical Biochemistry|January 31, 2004
A continuous nonradioactive assay for RNA-dependent RNA polymerase activityFrederick C Lahser, Bruce A Malcolm
Virology|August 13, 2010
A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replicationYann Benureau, Lucile Warter, Bruce A Malcolm, et al.
Virology|June 5, 2003
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNASifang Zhou, Rong Liu, Bahige M Baroudy, et al.
Antiviral Research|February 2, 2006
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034Xiao Tong, Robert Chase, Angela Skelton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 23, 2015
Half-life extension of the HIV-fusion inhibitor peptide TRI-1144 using a novel linker technologyEric L Schneider, Gary W Ashley, Lieve Dillen, et al.
Journal of Virology|December 25, 2003
Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibitionWenyan Wang, Frederick C Lahser, MinKyung Yi, et al.
Biochemistry|February 1, 2006
Impact of naturally occurring variants of HCV protease on the binding of different classes of protease inhibitorsXiao Tong, Zhuyan Guo, Jacquelyn Wright-Minogue, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Virus Research|September 9, 2005
Trans-complementation of HCV replication by non-structural protein 5AXiao Tong, Bruce A Malcolm
Analytical Biochemistry|January 31, 2004
A continuous nonradioactive assay for RNA-dependent RNA polymerase activityFrederick C Lahser, Bruce A Malcolm
Virology|August 13, 2010
A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replicationYann Benureau, Lucile Warter, Bruce A Malcolm, et al.
Virology|June 5, 2003
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNASifang Zhou, Rong Liu, Bahige M Baroudy, et al.
Antiviral Research|February 2, 2006
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034Xiao Tong, Robert Chase, Angela Skelton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 23, 2015
Half-life extension of the HIV-fusion inhibitor peptide TRI-1144 using a novel linker technologyEric L Schneider, Gary W Ashley, Lieve Dillen, et al.
Journal of Virology|December 25, 2003
Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibitionWenyan Wang, Frederick C Lahser, MinKyung Yi, et al.
Biochemistry|February 1, 2006
Impact of naturally occurring variants of HCV protease on the binding of different classes of protease inhibitorsXiao Tong, Zhuyan Guo, Jacquelyn Wright-Minogue, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Pageof 1